Discover how gut and oral bacteria influence immune evasion in esophageal cancer, impacting treatment response and disease ...

Esophageal squamous cell carcinoma (ESCC) is a deadly cancer with particularly high prevalence in East Asia. While ...

Fusobacterium nucleatum was notably abundant in OSCC tissues and actively participated in the conversion of L-glutamate to butyrate, a metabolite known to foster cancer cell proliferation.

In a study published in the Journal of Oral Microbiology, ADA Forsyth scientists found that FP 100 (Hygromycin A), a first-in-class, small molecule, narrow-spectrum antibiotic, successfully ...

By analyzing patient samples, Brazilian researchers identified the species Fusobacterium nucleatum in nearly 60% of cases, with a higher prevalence in oropharyngeal tumors. This ...

A recent study has made significant strides in uncovering how the oral microbiome, particularly the bacterium Fusobacterium nucleatum, plays a crucial role in the progression of oral squamous cell ...

First Narrow-Spectrum antibiotic FP100 (Hygromycin A) successfully eradicates Fusobacterium nucleatum, a key pathogen that triggers gum disease and is associated with colon cancer, pancreatic ...